Inhaled Amikacin for Treatment of Refractory Pulmonary Nontuberculous Mycobacterial Disease

Rationale: Treatment of pulmonary nontuberculous mycobacteria, especially Mycobacterium abscessus, requires prolonged, multidrug regimens with high toxicity and suboptimal efficacy. Options for refractory disease are limited. Objectives: We reviewed the efficacy and toxicity of inhaled amikacin in p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Olivier, Kenneth N., Shaw, Pamela A., Glaser, Tanya S., Bhattacharyya, Darshana, Fleshner, Michelle, Brewer, Carmen C., Zalewski, Christopher K., Folio, Les R., Siegelman, Jenifer R., Shallom, Shamira, Park, In Kwon, Sampaio, Elizabeth P., Zelazny, Adrian M., Holland, Steven M., Prevots, D. Rebecca
Format: Artigo
Idioma:Inglês
Publicat: American Thoracic Society 2014
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3972984/
https://ncbi.nlm.nih.gov/pubmed/24460437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201307-231OC
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars